# Lenalidomide Maintenance Therapy for Multiple Myeloma

> **NCT01675141** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 11 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT01675141
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08-20
- **Primary completion:** 2016-05-05
- **Final completion:** 2017-03-10
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Original investigator left the NIH and the primary outcome was not reached
- **Last updated:** 2018-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675141, "Lenalidomide Maintenance Therapy for Multiple Myeloma". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01675141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*